These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 20522442)

  • 1. High pregnancy rates with administration of granulocyte colony-stimulating factor in ART-patients with repetitive implantation failure and lacking killer-cell immunglobulin-like receptors.
    Würfel W; Santjohanser C; Hirv K; Bühl M; Meri O; Laubert I; von Hertwig I; Fiedler K; Krüsmann J; Krüsmann G
    Hum Reprod; 2010 Aug; 25(8):2151-2; author reply 2152. PubMed ID: 20522442
    [No Abstract]   [Full Text] [Related]  

  • 2. G-CSF after PBSC transplantation.
    Ojeda E; Garcia-Bustos J; Aguado MJ; Luaces MR; Arrieta R; Hernandez-Navarro F
    Br J Haematol; 1998 Jun; 101(3):594-6. PubMed ID: 9633910
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment with lenograstim (glycosylated recombinant human granulocyte colony-stimulating factor) and orthotopic liver transplantation for glycogen storage disease type Ib.
    Lachaux A; Boillot O; Stamm D; Canterino I; Dumontet C; Regnier F; Floret D; Hermier M
    J Pediatr; 1993 Dec; 123(6):1005-8. PubMed ID: 7693904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Granulocyte colony stimulating factor treatment of resistant thin endometrium in women with frozen-thawed blastocyst transfer.
    Kunicki M; Łukaszuk K; Liss J; Skowrońska P; Szczyptańska J
    Syst Biol Reprod Med; 2017 Feb; 63(1):49-57. PubMed ID: 27874292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of granulocyte colony-stimulating factor on the treatment of thin endometrium during frozen-thawed embryo transfer cycles: a retrospective cohort study.
    Lian R; Wang X; Lin R; Zeng H; Zeng Y; Liu S
    Gynecol Endocrinol; 2020 Apr; 36(4):370-374. PubMed ID: 31464150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of molgramostim, filgrastim and lenograstim in the treatment of myelokathexis.
    Cernelc P; Andoljsek D; Mlakar U; Pretnar J; Modic M; Zupan IP; Zver S
    Pflugers Arch; 2000; 440(5 Suppl):R81-2. PubMed ID: 11005621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two protocols to treat thin endometrium with granulocyte colony-stimulating factor during frozen embryo transfer cycles.
    Xu B; Zhang Q; Hao J; Xu D; Li Y
    Reprod Biomed Online; 2015 Apr; 30(4):349-58. PubMed ID: 25682303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Collection of Ph-negative progenitor cells with granulocyte-colony stimulating factor in patients with chronic myeloid leukaemia who respond to recombinant alpha-interferon.
    Reiffers J; Taylor K; Gluckman E; Gorin NC; Mahon FX; Micléa JM; Destrée D; Gautier L
    Br J Haematol; 1998 Aug; 102(3):639-46. PubMed ID: 9722288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of intrauterine administration of transfected peripheral blood mononuclear cells by GM-CSF on embryo implantation and pregnancy rate in mice.
    Rezaee D; Bandehpour M; Kazemi B; Salehi M
    Mol Hum Reprod; 2020 Feb; 26(2):101-110. PubMed ID: 31899496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Colony stimulating factors: G-CSFs--filgrastim (Neupogen) and lenograstim (Granocyte).
    MacConnachie AM
    Intensive Crit Care Nurs; 1998 Feb; 14(1):49-50. PubMed ID: 9652261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The efficacy of recombinant human granulocyte colony-stimulating factor and recombinant human granulocyte macrophage colony-stimulating factor in permitting the administration of higher doses of cyclophosphamide in a doxorubicin-cyclophosphamide combination. An NSABP pilot study in patients with metastatic or high-risk primary breast cancer. National Surgical Adjuvant Breast and Bowel Project.
    Mamounas EP; Anderson S; Wickerham DL; Clark R; Stoller R; Hamm JT; Stewart JA; Bear HD; Glass AG; Bornstein R
    Am J Clin Oncol; 1994 Oct; 17(5):374-81; discussion 382. PubMed ID: 7522393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Myeloid growth factors. New indications with many questions].
    Palmblad J; Samuelsson J; Glimelius B; Ljungman P; Nilsson PG
    Lakartidningen; 1994 Jul; 91(28-29):2675-8. PubMed ID: 7519704
    [No Abstract]   [Full Text] [Related]  

  • 13. Pilot study of granulocyte-macrophage colony-stimulating factor and interleukin-2 as immune adjuvants for a melanoma peptide vaccine.
    Block MS; Suman VJ; Nevala WK; Kottschade LA; Creagan ET; Kaur JS; Quevedo JF; McWilliams RR; Markovic SN
    Melanoma Res; 2011 Oct; 21(5):438-45. PubMed ID: 21697748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant hematopoietic growth factors in bone marrow transplantation.
    Nemunaitis J
    Cancer Treat Res; 1995; 76():225-48. PubMed ID: 7577337
    [No Abstract]   [Full Text] [Related]  

  • 15. Physicochemical and biochemical characteristics of glycosylated recombinant human granulocyte colony stimulating factor (lenograstim).
    Ono M
    Eur J Cancer; 1994; 30A Suppl 3():S7-11. PubMed ID: 7535073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A controlled study of recombinant human granulocyte colony-stimulating factor in elderly patients after treatment for acute myelogenous leukemia. AML Cooperative Study Group.
    Dombret H; Chastang C; Fenaux P; Reiffers J; Bordessoule D; Bouabdallah R; Mandelli F; Ferrant A; Auzanneau G; Tilly H
    N Engl J Med; 1995 Jun; 332(25):1678-83. PubMed ID: 7539109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor in chemotherapy for lung cancer.
    Saijo N; Eguchi K; Etou H; Miyachi S; Morinari H; Nakada K; Noda K; Ohkuni Y; Watanabe K; Yamada Y
    Semin Oncol; 1994 Feb; 21(1 Suppl 1):54-8. PubMed ID: 7512277
    [No Abstract]   [Full Text] [Related]  

  • 18. Lenograstim: an update of its pharmacological properties and use in chemotherapy-induced neutropenia and related clinical settings.
    Dunn CJ; Goa KL
    Drugs; 2000 Mar; 59(3):681-717. PubMed ID: 10776839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GM-CSF as adjuvant for immunotherapy with bispecific antibodies.
    Elsässer D; Stadick H; van de Winkel JG; Valerius T
    Eur J Cancer; 1999 Aug; 35 Suppl 3():S25-8. PubMed ID: 10645218
    [No Abstract]   [Full Text] [Related]  

  • 20. The therapeutic effect of granulocyte colony stimulating factor (G-CSF) on potential biochemical pregnancy in patients with unexplained repeated transplantation failure (RIF): a case series and literature review.
    Wu W; Xu GF; Hu YJ
    Gynecol Endocrinol; 2022 May; 38(5):443-447. PubMed ID: 35244509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.